Last reviewed · How we verify
AZD6482
At a glance
| Generic name | AZD6482 |
|---|---|
| Sponsor | AstraZeneca |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Bleeding Time Study With AZD6482, Clopidogrel and ASA (PHASE1)
- Study to Investigate Safety and Tolerability of a Single Dose of AZD6482 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |